Modification of RANKL-based peptide, MHP1, for clinical use in ischemic stroke

Munehisa Shimamura

Presentation information

English Poster Session

[Pe-001] Cerebrovascular disease (biomarker)

Wed. May 23, 2018 5:40 PM - 6:46 PM Poster Exhibition (Royton Sapporo / Royton Hall （3F）)

Chair: Shigeru Fujimoto(Division of Neurology, Department of Medicine, Jichi Medical University)Commentator: Kazutoshi Nishiyama(Department of Neurology, Kitasato University School of Medicine)

[Pe-001-2] Modification of RANKL-based peptide, MHP1, for clinical use in ischemic stroke

^○Munehisa Shimamura^1,2, Hironori Nakagami², Tomohiro Kawano^1,2, Kouji Wakayama³, Ryuichi Morishita⁴, Hideki Mochizuki¹ (1.Department of Neurology, Osaka University, 2.Department of Health Development and Medicine, Osaka University, 3.Department of Advanced Clinical Science and Therapeutics, the University of Tokyo, 4.Department of Clinical Gene Therapy, Osaka University)

Abstract password authentication.
Password is written on a pocket program and name badge.